Metacognitive Intervention in Children and Adolescents With ADHD - MiA Study

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of the MiA-Study is to address the current lack of effective treatment options to reduce cognitive and physical long-term problems in children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD). Through the use of the Mio-Training, cognitive development will be strengthened and metacognitive thinking and awareness will increase. The MiA-Study is conducted additionally to the Mio-study to evaluate the effectiveness of the Mio-Training specifically within the ADHD population. The Mio-Training for children and adolescence with ADHD includes a combination of cognitive and coordinative training tasks and prospective as well as retrospective metacognitive questions. In a randomized controlled trial, the Mio-Training will be analysed for its efficacy on metacognitive thinking and executive functions. In particular, the investigators are interested in factors that affect the efficacy of the training program such as compliance, age, sex or the severity of the ADHD. This study will give insight into the role of metacognition in cognitive performance and will foster the development of children and adolescents with ADHD in the long-term.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 8
Maximum Age: 16
Healthy Volunteers: f
View:

• Informed consent as documented by signature (see Informed Consent Form) of participants and / or one parent / legal guardian

• Age 8-16 years

• A diagnosis of ADHD (mild, moderate or severe)

• Intelligence \>85 (WISC-V short form)

• German or french speaking

• Willingness to perform the assessments without the medication (the study visits will take place without ADHD medication)

Locations
Other Locations
Switzerland
Insespital, University Hospital Bern
RECRUITING
Bern
Contact Information
Primary
Regula Everts, Prof. Dr. phil.
regula.everts@insel.ch
+41 31 632 84 97
Backup
Saskia Salzmann, MSc
saskia.salzmann@insel.ch
+41 31 664 59 84
Time Frame
Start Date: 2025-08-01
Estimated Completion Date: 2027-08-31
Participants
Target number of participants: 40
Treatments
Active_comparator: Training group
Training with Mio-Training for 5 weeks, three times per week.
No_intervention: Control group
Waiting control group. Participants may use the Mio-Training after completion of the last follow-up assessment.
Sponsors
Leads: Insel Gruppe AG, University Hospital Bern

This content was sourced from clinicaltrials.gov